OXFORD, England, Aug. 2, 2023 /PRNewswire/ -- Ultromics, a pioneer in advancing heart failure diagnostics through artificial intelligence (AI), has…
Three New IVL-Specific Diagnostic Related Groups (DRGs) with Increased Payments Go Into Effect October 1, 2023SANTA CLARA, Calif., Aug. 02,…
The strategic partnership will enable scalable chronic disease management, supporting RUSH’s transition to value based careNEW YORK & CHICAGO--(BUSINESS WIRE)--Cadence…
Latest data details how Medicare Advantage company drove greater reduction in members’ blood sugar levels and diabetes-related deaths, provided more…
NASHUA, N.H., July 31, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer…
89% and 84% of patients were maintained on ≥12- and ≥16-week dosing intervals, respectively, throughout the two-year period, while sustaining their…
Glidewell Receives PDAC-Approval for Silent Nite Sleep Appliance, Making It the Second Silent Nite Appliance Eligible for Medicare Reimbursement Using…
Raises 2023 GuidanceNASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), today announced financial and operating results for the second quarter ended June…
FT. MYERS, FL / ACCESSWIRE / July 27, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, announced…
-- Number of subjects increased from 12 to 60 ---- Portable Neuromodulation Stimulator (PoNS®) will be used to evaluate cranial-nerve…